Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 1
Submit an article Journal homepage
4,874
Views
8
CrossRef citations to date
0
Altmetric
Coronaviruses

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial

Lairun Jina School of Public Health, Southeast University, Nanjing, People’s Republic of ChinaView further author information
,
Rong Tangb National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of ChinaView further author information
,
Shipo Wuc Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People’s Republic of ChinaView further author information
,
Xiling Guob National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of ChinaView further author information
,
Haitao Huangd Cansino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Lihua Houc Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People’s Republic of ChinaView further author information
,
Xiaoqin Chene Donghai County Center for Disease Control and Prevention, Lianyungang, Jiangsu, People’s Republic of ChinaView further author information
,
Tao Zhud Cansino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Jinbo Goud Cansino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Jin Zhonge Donghai County Center for Disease Control and Prevention, Lianyungang, Jiangsu, People’s Republic of ChinaView further author information
,
Hongxing Panb National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of ChinaView further author information
,
Lunbiao Cuib National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of ChinaView further author information
,
Yin Chenb National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of ChinaView further author information
,
Xin Xiaf School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Jialu Fengf School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Xue Wangd Cansino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Qi Zhaod Cansino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
XiaoYu Xug Vazyme Biotech Co., Ltd, Nanjing, People’s Republic of ChinaView further author information
,
Zhuopei Lif School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Xiaoyin Zhanga School of Public Health, Southeast University, Nanjing, People’s Republic of ChinaView further author information
,
Wei Chenc Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Jingxin Lib National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of China;f School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China;h Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Fengcai Zhua School of Public Health, Southeast University, Nanjing, People’s Republic of China;b National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, People’s Republic of China;f School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China;h Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1644-0006View further author information
ORCID Icon show all
Article: 2155251 | Received 27 Oct 2022, Accepted 30 Nov 2022, Published online: 15 Dec 2022

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zezhong Liu, Lu Lu & Shibo Jiang. (2023) Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines. Emerging Microbes & Infections 12:1.
Read now
Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, Yuting Liao, Lingfeng Yuan, Gang Chen & Huakun Lv. (2023) Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Expert Review of Vaccines 22:1, pages 1079-1090.
Read now
Shen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, Jing-Xin Li & Feng-Cai Zhu. (2023) A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov. Expert Review of Vaccines 22:1, pages 704-713.
Read now

Articles from other publishers (5)

Nani Xu, Yu Xu, Rongrong Dai, Lin Zheng, Pan Qin, Peng Wan, Yejing Yang, Jianmin Jiang, Hangjie Zhang, Xiaowei Hu & Huakun Lv. (2023) Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study. Frontiers in Immunology 14.
Crossref
Fu-Zhen Wang, Chun-Huan Zhang, Lin Tang, Lance E Rodewald, Wen Wang, Si-Yu Liu, Wen-Ji Wang, Dan Wu, Qian-Qian Liu, Xiao-Qi Wang, Li-Fang Huang, Ao-Di Huang, Li-Ming Bao, Zhou-Bin Zhang & Zun-Dong Yin. (2023) An Observational Prospective Cohort Study of Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection of an Aerosolized, Inhaled Adenovirus Type 5–Vectored Coronavirus Disease 2019 Vaccine Given as a Second Booster Dose in Guangzhou City, China. The Journal of Infectious Diseases.
Crossref
Hangjie Zhang, Nani Xu, Yu Xu, Pan Qin, Rongrong Dai, Bicheng Xu, Shenyu Wang, Linling Ding, Jian Fu, Shupeng Zhang, Qianhui Hua, Yuting Liao, Juan Yang, Xiaowei Hu, Jianmin Jiang & Huakun Lv. (2023) Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults. Nature Communications 14:1.
Crossref
Rong Tang, Hui Zheng, Bu-Sen Wang, Jin-Bo Gou, Xi-Ling Guo, Xiao-Qin Chen, Yin Chen, Shi-Po Wu, Jin Zhong, Hong-Xing Pan, Jia-Hong Zhu, Xiao-Yu Xu, Feng-Juan Shi, Zhuo-Pei Li, Jing-Xian Liu, Xiao-Yin Zhang, Lun-Biao Cui, Zhi-Zhou Song, Li-Hua Hou, Feng-Cai Zhu, Jing-Xin Li, Hai-Tao Huang, Xiao-Long Li, Xue Wang, Peng Wan & Tao Zhu. (2023) Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial. The Lancet Respiratory Medicine 11:7, pages 613-623.
Crossref
Shen Wang, Bo Liang, Weiqi Wang, Ling Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2023) Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduction and Targeted Therapy 8:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.